Anavex Life Sciences
AVXL
$3.44
Share price
1.47%
Change (1 day)
-57.74%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) - Total debt
Total debt on the balance sheet as of June 2016 : $0.08 M
According to Anavex Life Sciences 's latest financial reports the company's total debt is $0.08 M. A company’s total debt is the sum of all current and non-current debts.
Anavex Life Sciences - Total debt on balance sheet (from 2006 to 2016)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2015-09-30 | $0.08 M | -98.55% |
| 2014-09-30 | $5.91 M | 430.27% |
| 2013-09-30 | $1.11 M | 272.86% |
| 2012-09-30 | $0.29 M | -65.55% |
| 2011-09-30 | $0.86 M | -65.18% |
| 2010-09-30 | $2.49 M | -6.81% |
| 2009-09-30 | $2.67 M | 72.55% |
| 2008-09-30 | $1.55 M | |
| 2006-09-30 | $0.02 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $6.16 M | 6,887.26% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.15 M | 71.14% | 🇺🇸 USA |
 Palatin Technologies PTN | $0.82 M | 830.93% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.82 B | 935,102.65% | 🇺🇸 USA |